176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
View analysts' price targets and recommendations, and compare them with competitors.
$207.00
Analysts expect the stock price to increase by 16.41%.
Buy
Positive consensus among analysts.
Analyze DCF forecasts for the company and compare them with competitors.
26.91B
Revenue has increased from the previous period.
61.40%
Revenue growth rate has increased from the previous period.
11.35B
EBITDA has increased from the previous period.
42.18%
EBITDA margin has increased from the previous period.
10.18B
EBIT has increased from the previous period.
37.81%
EBIT margin has increased from the previous period.
1.17B
Depreciation has increased from the previous period.
21.21B
Total cash has increased from the previous period.
78.80%
Cash percentage has increased from the previous period.
4.65B
Receivables have increased from the previous period.
17.28%
Receivables percentage has increased from the previous period.
2.60B
Inventories have increased from the previous period.
9.68%
Inventory percentage has decreased from the previous period.
1.78B
Accounts payable has increased from the previous period.
6.62%
Payables percentage has decreased from the previous period.
-976.00M
Capital expenditure has decreased from the previous period.
-3.63%
CapEx percentage has decreased from the previous period.
12.06%
WACC is unchanged from the previous period.
12.08%
Cost of equity is unchanged from the previous period.
4.26%
Cost of debt is unchanged from the previous period.
1.66
Beta is unchanged from the previous period.
24.94B
Diluted shares outstanding is unchanged from the previous period.
11.06B
Total debt is unchanged from the previous period.
3.35T
Total equity is unchanged from the previous period.
3.36T
Total capital is unchanged from the previous period.
0.33%
Debt weighting is unchanged from the previous period.
99.67%
Equity weighting is unchanged from the previous period.
9.98B
EBIAT has increased from the previous period.
7.82B
UFCF has increased from the previous period.
4.00%
Long-term growth rate is unchanged from the previous period.
1.62T
Terminal value is unchanged from the previous period.
1.12T
Enterprise value has increased from the previous period.
3.78B
Net debt is unchanged from the previous period.
1.12T
Equity value has increased from the previous period.
44.94
Equity value per share is unchanged from the previous period.
Analyze analyst forecasts for the company and compare them with competitors.
26.95B
The estimated revenue has increased from the previous period.
7.84B
The estimated EBITDA has decreased from the previous period.
0.33
The estimated EPS has decreased from the previous period.
10.33B
The estimated net income has decreased from the previous period.
6.74B
The estimated EBIT has decreased from the previous period.
1.95B
The estimated SG&A expenses have decreased from the previous period.
